My passion is direct patient care that is comprehensive in treating the "whole patient" and family-centered by including children and their families in the development of the care plan. As a pediatric hospitalist, I provide care to hospitalized pediatric patients of all ages from infancy thru adolescence that are acutely ill or have medically complex conditions. This includes providing pediatric consultation to subspecialty and surgical patients and coordination of care among multiple provider teams.
Education of patients and their families as well as medical students, residents, and colleagues is a fundamental part of my patient care activities. I also have a specific interest in development of individualized care plans for patients with complex medical care needs.
Barbara Asselin, MD, an attending physician and faculty member at URMC for over 25 years, graduated from Boston College, Boston, MA and then received her medical degree from University of Rochester School of Medicine & Dentistry. After completing her residency in Pediatrics at University of Massachusetts, Worcester, MA, she returned to Rochester and completed fellowship training in Pediatric Hematology/Oncology at the University of Rochester.
As a board-certified pediatrician and pediatric hematologist/oncologist, Dr. Asselin has provided care for pediatric patients with cancer and blood disorders, conducted research trials in pediatric malignancies, served as Principal Investigator to the Children's Oncology Group and Dana-Farber Leukemia Consortium, and authored numerous research studies, articles and book chapters related to her clinical and research interests. Since 2009, she has worked as an academic hospitalist in the division of Pediatric Hospital Medicine providing comprehensive inpatient medical care for children with acute and chronic illnesses. Dr. Asselin's academic interests include clinical research to improve the care of patients with pediatric cancers, medical education for medical students and residents, and development of individualized patient care plans for patients with complex, multispecialty needs.
Dr. Asselin's research expertise is in clinical trials and clinical research to improve the care of patients with pediatric cancers. She serves as study investigator for two major international cooperative research groups, the Children's Oncology Group and the Dana-Farber Leukemia Consortium.
Through these groups she is actively involved in design and development of a number of studies of the treatment and biology of acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL). Her specific areas of expertise are L-asparaginase pharmacology and immunology in treatment of ALL, treatment of T-cell disease (ALL and NHL), and the role of cardioprotection in prevention of cardiotoxocity in long-term survivors.
2004 - Present
Best Doctors in America
2003 - Present
Alpha Omega Alpha (AOA) Medical Honor Society
2002 - 2005
George Washington Goler Associate Professor of Pediatrics
Jacob Gitelman Award
Sponsor: Cancer Action and Gilda's Club of Rochester
1998 - Present
Society of Pediatric Research
1987 - 1990
Research Fellow, Leukemia Society of America
1987 - 1990
Wilmot Cancer Research Fellow
Sponsor: James P. Wilmot Foundation
1985 - 1986
Sponsor: Department of Pediatrics
Location: University of Rochester Medical Center
Rochester Academy of Medicine OB-GYN Annual Award
Paul Gyorgy Annual Award, La Leche League International
Honor Society of Phi Beta Kappa
Honor Society of the Order of the Cross and Crown
VIEW ALL expand_more
Ladas EJ, Orjuela M, Stevenson K, Cole PD, Lin M, Athale UH, Clavell LA, Leclerc JM, Laverdiere C, Michon B, Schorin MA, Welch JG, Asselin BL, Sallan SE, Silverman LB, Kelly KM. "Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohort." Clinical nutrition : official journal of the European Society of Parenteral and Enteral Nutrition.. 2019 Jan 3; Epub 2019 Jan 03.
Winter SS, Dunsmore KP, Devidas M, Wood BL, Esiashvili N, Chen Z, Eisenberg N, Briegel N, Hayashi RJ, Gastier-Foster JM, Carroll AJ, Heerema NA, Asselin BL, Gaynon PS, Borowitz MJ, Loh ML, Rabin KR, Raetz EA, Zweidler-Mckay PA, Winick NJ, Carroll WL, Hunger SP. "Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2018 Oct 10; 36(29):2926-2934. Epub 2018 Aug 23.
Athale UH, Puligandla M, Stevenson KE, Asselin B, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Sulis ML, Welch JJG, Harris MH, Neuberg DS, Sallan SE, Silverman LB. "Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001." Pediatric blood & cancer.. 2018 Oct 0; 65(10):e27256. Epub 2018 Jun 07.
Books & Chapters
Chapter Title: "Epidemiology of Childhood and Adolescent Cancer" in Nelson Textbook of Pediatrics".
Book Title: Nelson Textbook of Pediatrics
Author List: BL Asselin
Edited By: ed. Kliegman RM, Behrman RE, Stanton BF, Schor N, and St.Geme J.
Published By: WB Saunders 2011 in Philadelphia
Chapter Title: Pediatric Leukemias and Lymphomas
Book Title: Textbook of Radiation Oncology
Author List: Asselin, BL; Hudson, M; Constine, LS
Edited By: Leibel S. Phillips
Published By: WB Saunders 2010 in Philadelphia
Chapter Title: Epidemiology of Childhood and Adolescent Cancer
Book Title: Nelson Textbook of Pediatrics, 19th ed.
Author List: Kliegman RM, Behrman RE, Stanton BF, Schor N, and St. Geme J
Published By: WB Saunders 2010 in Philadelphia
VIEW ALL PUBLICATIONS